
May 28 (Reuters) - Moderna Inc MRNA.O:
MODERNA: HHS WILL TERMINATE CO'S AWARD FOR LATE-STAGE DEVELOPMENT OF PRE-PANDEMIC INFLUENZA VACCINES
MODERNA: WILL EXPLORE ALTERNATIVES FOR LATE-STAGE DEVELOPMENT AND MANUFACTURING OF H5 PROGRAM
MODERNA: PHASE 1/2 H5 AVIAN FLU VACCINE STUDY SHOWS POSITIVE INTERIM RESULTS